Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Flibanserin in Women on SSRIs/SNRIs with Decreased Sexual Desire
NCT01040208Phase 3Terminated
- Sponsor
- Sprout Pharmaceuticals
- Start
- Jan 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flibanserin in hypoactive sexual desire disorder (HSDD), sponsored by Sprout Pharmaceuticals. Started Jan 2010; status: terminated.
02
Drugs
flibanserin
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT01040208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01040208.